GERIATRIC NUTRITIONAL RISK INDEX AS A SIGNIFICANT PROGNOSTIC FACTOR IN PATIENTS WITH CLEAR-CELL RENAL CELL CARCINOMA

被引：0
|
作者：
Yanagida, Kazuki
Watanabe, Daisuke
Yagi, Risako
Yoshida, Takahiro
Kawai, Taketo
Kaneko, Tomoyuki
Mizushima, Akio
Nakagawa, Tohru
机构：
来源：
JOURNAL OF UROLOGY | 2024年 / 211卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP36-11
引用
收藏
页码：E596 / E596
页数：1
相关论文
共 50 条
  • [31] RENAL Nephrometry Score: A Preoperative Risk Factor Predicting the Fuhrman Grade of Clear-Cell Renal Carcinoma
    Chen, Shao-Hao
    Wu, Yu-Peng
    Li, Xiao-Dong
    Lin, Tian
    Guo, Qing-Yong
    Chen, Ye-Hui
    Huang, Jin-Bei
    Wei, Yong
    Xue, Xue-Yi
    Zheng, Qing-Shui
    Xu, Ning
    [J]. JOURNAL OF CANCER, 2017, 8 (18): : 3725 - 3732
  • [32] Expression of Aquaporin 1 in Primary Renal Tumors: A Prognostic Indicator for Clear-Cell Renal Cell Carcinoma
    Huang, Ying
    Murakami, Takayuki
    Sano, Futoshi
    Kondo, Keiichi
    Nakaigawa, Noboru
    Kishida, Takeshi
    Kubota, Toshinobu
    Nagashima, Yoji
    Yao, Masahiro
    [J]. EUROPEAN UROLOGY, 2009, 56 (04) : 690 - 698
  • [33] Is adjuvant immunotherapy worth for all patients with clear-cell renal cell carcinoma at high risk of recurrence?
    Campi, R.
    Amparore, D.
    Marandino, L.
    Bertolo, R.
    Erdem, S.
    Ingels, A.
    Muselaers, S.
    Pavan, N.
    Roussel, E.
    Carbonara, U.
    Pecoraro, A.
    Diana, P.
    Pecoraro, A.
    Marchioni, M.
    [J]. EUROPEAN UROLOGY, 2023, 83 : S676 - S677
  • [34] Identification and validation of a genetic risk signature associated with prognosis in clear-cell renal cell carcinoma patients
    Lian, Meiqin
    Feng, Yueyuan
    Wu, Zhenyu
    Zheng, Zhonghong
    Liu, Huanhuan
    Li, Jian
    Yu, Huixia
    Lian, Changlin
    [J]. MEDICINE, 2023, 102 (31) : E34582
  • [35] Pazopanib in Patients with Clear-Cell Renal Cell Carcinoma: Seeking the Right Patient
    Porta, Camillo
    Ferrari, Alessandra
    Czarnecka, Anna M.
    Szczylik, Cezary A.
    [J]. FRONTIERS IN PHARMACOLOGY, 2017, 8
  • [36] Fibroblast growth factor receptors as therapeutic targets in clear-cell renal cell carcinoma
    Sonpavde, Guru
    Willey, Christopher D.
    Sudarshan, Sunil
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2014, 23 (03) : 305 - 315
  • [37] Metastatic clear-cell renal carcinoma to the parotid
    Lau, Steve Yee Chiang
    Chittleborough, Timothy John
    McCracken, James Albert
    Wijeratne, Shiran
    [J]. ANZ JOURNAL OF SURGERY, 2012, 82 (10) : 760 - 761
  • [38] Cholesterol and the development of clear-cell renal carcinoma
    Drabkin, Harry A.
    Gemmill, Robert M.
    [J]. CURRENT OPINION IN PHARMACOLOGY, 2012, 12 (06) : 742 - 750
  • [39] Is Adjuvant Immunotherapy Worth for All Patients with Clear-cell Renal Cell Carcinoma at High Risk of Recurrence?
    Marchioni, Michele
    Amparore, Daniel
    Marandino, Laura
    Bertolo, Riccardo
    Erdem, Selcuk
    Ingels, Alexandre
    Muselaers, Stijn
    Kara, Onder
    Pavan, Nicolo
    Roussel, Eduard
    Carbonara, Umberto
    Pecoraro, Angela
    Diana, Pietro
    Peccraro, Alessio
    Campi, Riccardo
    [J]. EUROPEAN UROLOGY OPEN SCIENCE, 2022, 46 : 39 - 42
  • [40] SIGNIFICANCE OF GERIATRIC NUTRITIONAL RISK INDEX AS A PROGNOSTIC PREDICTOR IN PATIENTS WITH NON-METASTATIC RENAL CELL CARCINOMA UNDERGOING SURGICAL RESECTION
    Tei, Hiromoto
    Miyake, Hideaki
    Fujisawa, Masato
    [J]. JOURNAL OF UROLOGY, 2015, 193 (04): : E692 - E693
12345